Tenax Therapeutics Inc reports results for the quarter ended in December - Earnings Summary

Tenax Therapeutics

31/03/2023 20:45

* Tenax Therapeutics Inc  TENX.OQ  reported a quarterly
adjusted
loss of $1.73​​ per share for the quarter ended in December. The
mean expectation of two analysts for the quarter was for a loss
of $2.28 per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Tenax Therapeutics Inc's reported EPS for the quarter was
a loss
of $1.73​.
    * The mean earnings estimate of analysts had fallen by
about 34.1%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Tenax Therapeutics Inc shares had fallen by 78.0% this
quarter.
    * The company reported a quarterly loss of $2.55 million.
    * Wall Street's median 12-month price target for Tenax
Therapeutics Inc is $43.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 31 at 07:45 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -2.28          -1.73          Beat
 Sep. 30 2022      -2.10          -2.20          Missed
 Jun. 30 2022      -1.80          -2.20          Missed